The Odyssey Proved IMAX’s Earnings Power. The Next Test Is a Broader Slate

Results vs. Consensus

Q3 FY2026 scorecard

Quarterly consensus among the main panels ranged from $168.20M to $168.53M in revenue and $1.02 to $1.06 in adjusted diluted EPS. The revenue surprise was modest beside the year-over-year growth: the market already expected a large box office contribution.

Year-over-year comparison

Quarterly cash flow figures are nine-month totals less first-half totals.

Quarter-over-quarter comparison

Revenue. Q2 showed that system sales could carry the business through a nearly flat box office quarter. Q3 showed the other side of the model: film remastering and revenue sharing from existing screens carried growth as technology sales slipped to $18.9M from $19.4M. The company was able to earn on the same ticket through its arrangement with a studio and, where it shares revenue with an exhibitor, through the installed system.

Margins. Q3 gross margin rose from 63.1% to 72.3%, and operating margin reached 42.9% from 27.2%. Adjusted EBITDA rose $69.1M, more than the revenue increase, because operating expenses grew slowly and the EBITDA measure adds back items including depreciation, film amortization and the goodwill impairment. We see a stronger annual margin case, but film volume and the quarterly mix of installations still drive wide swings in profitability.

Earnings. GAAP diluted EPS rose to $1.96 from $0.37, and company-adjusted EPS rose to $2.21 from $0.47. Management's $1.58 comparison removes the $36.7M allowance release attributable to tax assets expected to be used in future years. The full release was $59.0M; removing it puts adjusted EPS near $1.19, still above both consensus panels before any other tax normalization. We use management's approximately 27% forward tax assumption, with room for jurisdiction mix and discrete items. The Canadian reassessments disclosed in the filing cover about $102M of historical taxable income, rather than a $102M tax bill. Even while contested, they may push cash taxes above book tax expense and slow the conversion of profits to cash.

Segment Performance

Segment dollars are rounded; the consolidated row is from the income statement.

Content Solutions

Film remastering and distribution generated $90.4M of the $94.0M segment total. Q2's 63.2% gross margin had raised the question of whether IMAX was keeping enough of the premium ticket to offset its content costs. This quarter cleared our 66% test at 76.3%. The film take rate at 70mm venues was higher, and the scale of The Odyssey let remastering costs serve a much larger audience.

“Our box office results include a significant contribution from the 41 70mm film locations, which delivered 13% or $92 million of the Q3 box office, resulting from the virtually sold-out run of The Odyssey at these locations, and where we realized a higher average film take rate to support the unique requirements around distributing and projecting 70mm film.”
— Natasha Fernandes, Chief Financial Officer

Assessment: The recovery clears the immediate margin concern. We still need to see Q4 hold above 66% on a different mix of films before treating the recovery as durable. A broader slate can generate more total ticket sales without generating the same margin if fewer shows use film or if remastering costs are spread over more titles.

Technology Products and Services

System rentals rose to $41.4M from $23.0M, and contract renewals also helped offset lower system installation revenue. A greater share of rental revenue fell to gross profit because the cost of operating those revenue-sharing systems moved little. This is the complement to Q2's system sales and renewals strength. The earnings mix can switch between upfront installations and recurring economics even with the same network.

“IMAX delivered revenues of $77 million, a growth of 28% from the prior year, driven primarily by the higher box office performance fueled joint revenue sharing rental revenues, along with the higher revenues from the system contract renewals. The incrementality in our model, along with the positive mix shift to higher margin revenue streams, led to a gross profit margin of 69% or an 1,100 basis point increase year-over-year for the technology segment.”
— Natasha Fernandes, Chief Financial Officer

Assessment: The higher segment margin does not establish that IMAX captured a greater percentage of exhibitor ticket sales. Rentals grew more slowly than total global box office, even as the share of ticket sales coming back as rental revenue on sharing systems increased. Our FY27 estimates allow installed screens and renewals to drive growth without assuming a broad increase in contract take rates.

All Other

Revenue more than doubled to $3.3M, mainly because The Odyssey lifted the company's owned theatre. Gross profit rose to $1.2M, with gross margin broadly unchanged. IMAX also wrote off the remaining $6.8M of goodwill in its Streaming and Consumer Technology reporting unit after a change in offerings and expected cash flows.

Assessment: The theatre gain does not validate the consumer technology business. We assign no premium to its new licensing agreements until they demonstrate repeat sales and profit.

Network and box office indicators

The quarter-end figures and call-date figures tell different stories. Just eight of the 20 Q3 signings were new locations. By the call, 26 further signings took the year-to-date count to 105, and management said 65% of that larger total were new sites. This improves the demand signal for expansion even though quarter-end contracted backlog fell.

Key Topics & Management Commentary

Overall Management Tone: Management was more willing than in July to translate its confidence into a higher full-year outlook. It was still measured when asked for a 2027 box office figure or a faster installation schedule, where the outcomes depend on studios and exhibitors.

1. Scarcity is paying off in both film and digital

The Odyssey cleared the prior recap's $250M lifetime IMAX test by a wide margin. It reached more than $550M by the release, exceeding 30% of the film's total global gross. Within Q3, the 41 film locations accounted for $92M of the company's $712.1M in box office. Most of the dollars therefore came from the wider network, while the much smaller film footprint demonstrated an unusually valuable premium.

“Obviously, the exhibitors set the prices, not us, but we've shared that data with a lot of people, and we will continue to do that. I think that's just an obvious opportunity, and even dynamic pricing, which you look at is used so successfully in other businesses like airlines or Broadway shows or whatever. We're going to put the facts out there, and we hope that people understand they have more pricing power.”
— Richard Gelfond, Chief Executive Officer

Assessment: Higher 70mm ticket prices can increase what IMAX earns per ticket at sold-out venues even if its take rate stays the same, but exhibitors control price and one successful title gives little evidence about broader price sensitivity. We underwrite the format's ability to attract audiences and studios; we leave an industry-wide shift to dynamic pricing out of the base case.

2. The 2027 slate is deeper and still has to replace one enormous title

The Odyssey accounted for about 76% of Q3 box office. That is evidence of what Filmed For IMAX can deliver and of the concentration risk we flagged in July. Dune: Part Three had more than $30M in IMAX presales through its first month of play, a useful signal for December and January. Those sales are for screenings across both years, so we do not treat them as Q4 box office.

“We will have four IMAX 70mm film releases next year and at least 12 Filmed for IMAX releases, including a strong slate, which includes Star Wars: Starfighter, a return to the swashbuckling origins of the franchise, starring Ryan Gosling, which will also be presented in IMAX 70mm film.”
— Richard Gelfond, Chief Executive Officer

Assessment: Four 70mm releases meet the prior signpost. The calendar offers more ways to fill screens, from Star Wars: Starfighter and Avengers: Secret Wars to more international content after Japan's and India's first Filmed For IMAX releases in Q4 FY2026. We model roughly flat FY27 box office: a collection of strong titles can match FY26, but that takes several successes and careful screen allocation.

3. Greater China recovered on the screen before it did on the balance sheet

Greater China revenue rose to $28.4M from $20.3M in Q3, helped by The Odyssey and Spider-Man: Brand New Day, but fell to $62.8M from $78.1M over nine months. The filing also attributes higher credit reserves to deteriorating quality at specific Chinese customers. We did not get a like-for-like outcome for the earlier Spider-Man versus Avatar: Fire and Ash presale comparison.

“China's become a better story for us. The first half of this year was pretty weak in China, and we were significantly behind budget for the year in China. But we had the strongest summer we've ever had in China, and The Odyssey was one of the factors, but certainly not the only one. There were a lot. Summer came on strong.”
— Richard Gelfond, Chief Executive Officer

Assessment: China is recovering for IMAX on major titles. An exclusive early window for Avengers: Doomsday, a late December China date for Dune, and The Wandering Earth 3 for Chinese New Year give the recovery a path into 2027. We would need local-language receipts and better exhibitor collections to conclude that the regional earnings and credit risk has receded.

4. New contracts can improve the network without accelerating near-term installations

By the call, 71 systems had been signed in rest-of-world markets, compared with 39 in all of 2025. The mix of more new locations and underpenetrated markets matters for future maintenance and revenue sharing. Smaller premium auditoriums could add sites in cities that cannot accommodate the existing footprint, though pilot cost and seating economics are still unknown.

“Looking at installations, coming off our strongest second quarter in a decade, the pace of installations took a breather as exhibitors prioritized keeping their IMAX auditoriums open for The Odyssey and Spider-Man. We installed 32 systems in the quarter compared to 38 in the prior year.”
— Natasha Fernandes, Chief Financial Officer

Assessment: The September backlog fell to 409 from 421 in June, below our 420 watch level; the sales bucket declined to 231 from 234 while retaining a higher share than a year earlier. The filing repeats 17 year-to-date China cancellations already disclosed in Q2, and gives no new cancellation count. Stronger signings improve the pipeline, but construction limits and the seasonally heavy Q4 calendar keep us from pulling forward FY27 revenue.

5. Revenue sharing earns attractive margins on installed screens and still takes cash to grow

IMAX generated $86.1M of operating cash flow in Q3 and $100.3M of free cash flow over nine months after equipment for revenue-sharing arrangements. The year-to-date cash flows already include about $12M of exhibitor lease incentives in operating cash and $14M of revenue-sharing equipment investment in investing cash. The quarter ended with $208M in cash and $251M in gross debt, and IMAX did not repurchase shares in Q3.

“I think the one thing that we want to make sure is that we are being as helpful as possible so that we can expand our network at a faster pace, especially when it comes to JVs, because as you saw, we think about our incrementality when it comes down to the JV network. That incrementality can go all the way up to 100% flow-through from the 85. That simply just comes from the fact of our costs are fixed, and there is no ebbs and flows on those costs. We saw that happen in Q3, where our JV incrementality was at right up to 100%.”
— Natasha Fernandes, Chief Financial Officer

Assessment: Revenue sharing can earn more over a successful site's life than an upfront sale, but high incremental margins on existing screens say little about returns on the next dollar of equipment or lease support. We favor financing selectively where per-screen attendance supports the upfront spend. A larger share of growth financed this way would make cash conversion a more useful test than the margin target alone.

6. Exclusive programming and merchandise widen the offer with different economics

IMAX expects to show Netflix's The Further Misadventures of Cliff Booth at more than 550 locations worldwide, with exhibitors free to decline the limited theatrical window. IMAX also booked $2.3M of branded and studio merchandise revenue in Content Solutions in Q3, then planned a full Dune line. It agreed to certify Meta's planned VR glasses. The exclusive show uses capacity that could otherwise play another film; merchandise and certification are separate ways to earn from the brand.

“We see a real opportunity in IMAX collectibles and other merchandise, which we continue to pursue with efforts like our Godzilla Minus Zero IMAX apparel, which is available right now, a full line of products tied to December's release of Dune: Part Three, and merch tie-ins to 2027 key releases, as well as efforts to expand the business further internationally.”
— Richard Gelfond, Chief Executive Officer

Assessment: Programming can make less crowded weeks more productive, but the Thanksgiving window illustrates the cost when a competing film already has a claim on screens. Broader merchandising and licensing can add income without requiring another auditorium, though IMAX gave no merchandise profit or licensing economics. We do not assume the blockbuster merchandise sales recur each quarter.

Guidance & Outlook

The Q2 debate was whether keeping box office at $1.4B hid offsets to The Odyssey. China really was behind plan in the first half, but the Q3 reset shows the upside more than absorbed that drag at the group level. With $1.257B through September, Q4 needs just over $143M to exceed the old hurdle; the company said 2026 had already passed FY25's record with two months left. Our $1.58B estimate requires about $323M in Q4 and about $1.04B for H2, above our prior $900M upside marker.

Installation and margin math. IMAX finished September with 89 installations. It needs 71–86 in Q4, compared with 65 in Q4 FY2025. By the call, 125 were installed or underway, which supports the schedule without counting unfinished projects as completed. At our $490M revenue estimate, a 50% FY26 adjusted EBITDA margin would require about $46M in Q4 adjusted EBITDA, or roughly 35% on projected quarterly sales. The outlook can be met even if margin falls sharply from the summer peak.

Reading the outlook. The higher box office language establishes a floor and leaves the size of the upside open. Management gave no revenue or EPS target to compare against Street estimates, and said it expects to give FY27 box office guidance early next year, when holiday carryover and the local slate are clearer.

Analyst Q&A Highlights

When new signings can become installations

The question was whether stronger demand could pull forward existing commitments. Management distinguished a potentially faster process for future agreements from the permits and work crews already in the schedule.

Q: “Rich, I am curious now with the success of The Odyssey and IMAX's continued market share gains just across all movies, with the signings that you are doing now and what you have in the backlog, is it possible to accelerate installations and push those installations maybe forward a bit from your backlog so that we now see maybe higher installation numbers in not just 2027, but 2028 and 2029 as well too?”
— Eric Handler, Roth Capital Partners

A: “I think the cadence might change, but I think it is a little late in the game to affect 2026 or 2027, because again, without boring you with the real-world details, there are permits, there are work crews. You cannot just turn it on like a light switch, but maybe you could influence the cadence.”
— Richard Gelfond, Chief Executive Officer

Assessment: The potential benefit is in shorter time to revenue over several years. A larger FY27 installation assumption would need evidence that exhibitor construction schedules have actually moved.

How IMAX could add more 70mm screens

The path to more film screens involves repurposing existing equipment; management still needs to work out the launch economics.

Q: “Rich, you've remarked in the recent past the challenges around adding 70mm locations. What has changed, and what is the timeframe for those launches?”
— Drew Crum, B. Riley Securities

A: “Someone realized that we have between 10 and 15 3D film theaters. Think of it as projectors that have the ability to show two films at the same time. We came to the realization it's unlikely there will be 3D film locations, so we're in the process of figuring out how to split those 3D film projectors into two projectors, and you've got to put a business model around it, figure out how to price it, and do things like that. We're pretty confident we can do this, but exactly the dating, how long it'll take, and what the costs are, we're working through, so that's specifically why we didn't give more detail.”
— Richard Gelfond, Chief Executive Officer

Assessment: Reusing projection equipment could lower the cost of selective expansion. Prints, suitable rooms and enough long runs still determine returns, so the proposed 10–15 locations are upside to the network rather than part of the base case.

Why rental revenue lagged global box office growth

Management cited film and local market mix and pointed to the operating leverage of existing sharing systems. The useful distinction is the denominator: segment system rentals were 5.8% of all IMAX box office, down from 6.3%, but rose to 16.2% from 14.9% against ticket sales on joint revenue sharing systems. Neither ratio is a new contractual rate.

Q: “Your record box office flowed nicely through the film remastering and distribution line, but I was wondering why the system rentals take rate was less than the prior year. What are the puts and takes there?”
— David Joyce, Seaport Research Partners

A: “There's always puts and takes, but I think part of it just comes from the mix of films in the quarter, and we actually had a lot of box office flowing through, and I think part of it is you can actually see a high incrementality come through in the system rentals when you hit certain levels. But I just think part of it comes from local markets as well, and all of those pieces that flow through. But we actually had a very high flow-through when it comes through from The Odyssey, and as you saw in the EBITDA margin, 69% was the highest in our history.”
— Natasha Fernandes, Chief Financial Officer

Assessment: The rental business should be judged on incremental gross profit and site returns, not on consolidated box office alone. A strong title can generate more gross profit while the share of its ticket sales played on systems that remit rent shifts with geography and screen mix.

When IMAX asks an exhibitor for a larger share of the gate

The exchange clarified the scope of the Q2 thesis that cash incentives can buy stronger economics. The CFO tied the conversation to contracts in which IMAX contributes more capital.

Q: “Following up on the last question, Natasha, how much leverage do you have as you go to new partners to get more economics out of these JVs, if you raise the bar on what you are demanding as a rev share?”
— Steven Frankel, Rosenblatt Securities

A: “I think part of that comes down to, yes, we are negotiating, and I think where we give that construction cost or the lease incentives to our exhibitors, that is where we have an opportunity to definitely have a conversation about what the take rates are, because we are giving more. I think part of it just comes down to taking more market share means we are getting more revenue in the end, right? Being a good partner of keeping reasonable rates makes us grow our platform even larger too.”
— Natasha Fernandes, Chief Financial Officer

Assessment: Higher take rates can justify financing sites with good attendance. They do not create a free margin gain because cash goes out up front and is recovered only as the site earns.

What could let the 2027 slate grow from a record year

The question was whether next year's slate could grow against FY26. Management is waiting to assess holiday carryover and the Chinese New Year titles before setting a target.

Q: “I know you are not providing 2027 box office guidance yet, and you guys talked about being well above your 2026 guidance. Maybe talk a little bit about the puts and takes of what you see in 2027 that could potentially provide a path to growth over 2026.”
— Eric Wold, Texas Capital Securities

A: “Well, in general, Eric, we are going to give guidance sometime early next year. We just looked at historical patterns, and that is generally when we do it. Also, this year provides a unique opportunity because we have the flow-over of Avengers and Dune: Part Three and the really strong Chinese New Year slate, so we want to better understand that as we put together a number.”
— Richard Gelfond, Chief Executive Officer

Assessment: The carryover is meaningful because it can support the early part of FY27 before new releases arrive. We give it credit in the annual estimate without assuming the full film calendar is fixed today.

How much control IMAX has over the Netflix window

The exhibitor dispute concerned the short window and a competing release, as well as the exclusivity. Management said the parties chose not to invoke contractual programming rights after the late schedule change.

Q: “And then separate question, there has been some noise around Cliff Booth with your exhibitor partners. The issue seems to be more about the length of the window than the IMAX exclusivity. So just want to get your view on how you will proceed there and whether you still see room for that kind of IMAX exclusive model on a go-forward basis.”
— David Karnovsky, J.P. Morgan

A: “When Narnia was moved to February and Cliff Booth came on the calendar, it was kind of late in the game, and Hunger Games was already scheduled to be released right before Cliff Booth. We and Netflix agreed that we were not going to use our programming language because we wanted to be user-friendly, given the last-minute nature, to our exhibition partners. We gave them the option of whether to play it or not.”
— Richard Gelfond, Chief Executive Officer

Assessment: Selective windows can differentiate the IMAX slate, but participation depends on the exhibitor's alternatives. This experiment is a poor basis for assuming future exclusives can fill the entire network.

What They're NOT Saying

1. Ordinary-quarter film economics. IMAX has quantified its best quarter. It has yet to show that Content Solutions can sustain the recovered margin on several medium-sized releases with a less favorable 70mm mix.
2. The return on new revenue-sharing commitments. No size, payback period or site-level return was given for lease support or new capital structures. That gap matters if network growth requires more upfront investment than in the recent sales-heavy mix.
3. A timetable for cash-tax normalization in Canada. The filing gives the scope of the reassessments, but neither their timing nor the amount of incremental cash tied up is clear. We leave the baseline balance sheet intact and account for the uncertainty in the downside multiple.
4. New format and brand contribution. The company gave no price or launch schedule for 70mm conversions, no seat or cost targets for smaller pilots, and no merchandise margin or VR economics. Success could add earnings; today's figures support no separate premium.

Market Reaction

• Pre-print setup: IMAX closed November 4 at $51.76, up 40.0% YTD versus 12.3% for the S&P 500, up 2.3% over 30 days and 54.2% over 12 months. Its pre-print 52-week closing range was $32.53–$56.33.
• November 5 reaction session: IMAX opened at $53.05 (+2.5%), traded from $48.02 to $53.75 and closed at $48.13 (−7.0%). Volume was 2.6× the 30-day average.
• Benchmark and exhibitors: The S&P 500 fell 4.4%, Cinemark fell 0.8%, and AMC fell 12.5% following its own results after the previous close.

The initial gain fits the operating beat and the raised outlook. The broad selloff makes the closing decline a poor measure of how investors marked down IMAX's outlook. The stock still lagged the S&P 500 by about 2.6 percentage points. Given the pre-print run, a quarterly beat with a known film catalyst and a discrete tax gain offered less new information about FY27 than the headline EPS suggested. We see that as a plausible reason for the stock's extra weakness, without treating a single session as proof.

The lower close matters for prospective returns. Investors now pay close to July's post-results price for a company with higher earnings from existing screens, better cash generation and still meaningful release and installation risk.

Street Perspective

Can a stronger calendar replace the biggest film in IMAX history?

Bull view: The format's share of major releases and the supply of purpose-built films can sustain a record annual gate even without a single title at the same scale.

Bear view: With three quarters of Q3 box office coming from one title, schedule breadth says little about how much earnings the next group of films can replace.

Our take: Flat annual box office is a demanding but plausible starting point given four film releases and a wider slate. Maintenance and renewals offer a clearer path to EBITDA growth than a forecast that requires another record title.

Is the late signings burst worth paying for today?

Bull view: International exhibitors signing new sites after a record summer is evidence that consumer demand can expand the addressable network.

Bear view: Backlog kept falling into September, and more projects funded by IMAX could delay the cash return even if installations rise.

Our take: The new-location mix deserves credit, but we value the signings through ordinary additions and better recurring revenue. A faster rollout would be more valuable once openings and cash returns follow.

Is the selloff an entry point or an earnings trap?

Bull view: Supportive Street views emphasize premium share gains and a stronger slate. A broad-market selloff makes those cash flows available at a lower price.

Bear view: The tax benefit and blockbuster mix flatter trailing multiples. The 2027 earnings base must stand on much less spectacular quarters.

Our take: We give no valuation credit to the tax release. The stock is attractive at the reaction close on a modest FY27 operating increase, but the downside if film traffic and cash conversion fall together is large enough to keep conviction unchanged.

Our Estimates & Valuation

FY26 bridge. Our $490M revenue and $252M adjusted EBITDA estimates start with $358.8M and $199.4M through September, leaving $131.2M and $52.6M in Q4. We expect Q4 revenue slightly above FY25's $125.2M on installations and the holiday slate, but adjusted EBITDA below last year's $57.1M. The late December release schedule shifts some high-margin box office into January, while a larger share of Q4 installations is likely to be revenue sharing, which contributes less upfront than a sale. We assume $23M of Q4 adjusted income to common after about $19M of depreciation, net interest and other deductions combined, a 27% tax rate and about $1.5M for minorities. Adding that to $161.7M through September and dividing by approximately 57M FY26 diluted shares gives about $3.24 of adjusted EPS, or $2.20 without the full $59.0M allowance release.

FY27 bridge. We estimate about $200M of Content Solutions, $303M of Technology Products and Services and $12M of All Other revenue, versus $202M, $277M and $11M in our FY26 estimate. We estimate that about 40% of FY26 ticket sales will be on revenue-sharing systems, close to the 39% share through September, versus 44% a year earlier. Our FY27 case moves that back to about 45% as more sharing systems contribute for a full year and the slate shifts away from The Odyssey quarter, when only 36% of the gate was on sharing systems. A five-point mix shift on $1.58B of box office at a 16% effective rental yield adds about $13M of rental revenue; maintenance adds about $3M on a larger installed base. System sales and renewals add $10M: roughly $5M from six more sale or sales-type installations within a similar total installation count, and $5M from amendments and renewals. Amendments, renewals and other adjustments added $6.3M of year-over-year growth through September. If the box office mix stays at 40%, the lost rentals alone would take about $8M off FY27 EBITDA at our assumed incremental margin.

Compared with July's midpoints, we lower FY27 revenue to $515M from $530M and raise adjusted EBITDA to $265M from $255M. A more typical film slate earns less per box office dollar than a record 70mm quarter; more rentals and maintenance on systems already in place mean higher flow-through on the growth we do expect. Applying roughly 60% incremental gross profit to the tech increase and subtracting the lost content contribution and modest expense growth gets to about $13M of EBITDA growth from FY26. For adjusted EPS, $265M less $80M in depreciation and amortization and $9M in net interest and other deductions, taxed at 27% and reduced by $8M for minorities, gives about $2.10 per share on 57.5M diluted shares. Normalized EPS falls modestly from FY26 even as EBITDA rises, reflecting the reset in taxes and higher depreciation and dilution.

12-month fair value: $52–$61, previously $48–$58. We continue to value FY27 EBITDA. We apply 12–14× to an estimated $249M attributable to IMAX shareholders (94% of $265M, in line with the nine-month and trailing proportions), equivalent to 11.3–13.2× consolidated EBITDA versus the prior approximate 11–13.5× band. Higher EBITDA and lower net debt explain the increase. We use $43M of consolidated September net debt as a proxy and 56.5M shares including an allowance for employee equity dilution. About $122M of cash was held in mainland China, so some may be unavailable to the parent or taxable on remittance. A $35M reduction in the cash we credit would lower the base case by about $0.62 per share. We count the note principal as debt, with an adjustment for net conversion dilution above the $57.10 capped-call price. There is no assumed cash dividend or buyout premium.

The $56.55 base case offers about 17.5% over 12 months, against a high-single-digit planning return for the S&P 500. In the downside case, roughly $200M less box office cuts content and rental revenue by about $36M, and delayed installations take away another $8M. At roughly 70% EBITDA flow-through on those lost revenues, plus $14M for weaker mix and largely fixed costs, EBITDA falls about $45M to $220M. We use 10.5× in that case because the lower cash earnings would weaken the case for a premium multiple. The upside requires several titles to convert strongly and backlog to recover, with healthier cash returns on new sites. We expect enough operating progress to favor IMAX versus the index, but the credible downside keeps the conviction at 7 out of 10.

Thesis Scorecard Post-Earnings

Overall: The premium format and operating leverage theses strengthened. The stock now offers better prospective returns than in July, but the installation schedule, geographic credit quality and the unusual concentration of Q3 still limit how much of the beat we carry into FY27.

Action: Maintain Outperform. The next tests are completing 160–175 installations, holding Content Solutions gross margin above 66% in Q4 and demonstrating that the signings pickup can stabilize backlog. We would reassess if the holiday slate and systems schedule both disappoint enough to put FY27 EBITDA on the path toward our $220M downside case, or if the price reaches the top of our fair value range without corresponding estimate gains.